Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases

被引：0
|
作者：
Dewit, O. [1 ]
机构：
[1] St Luc Univ Hosp, Dept Gastroenterol, B-1200 Brussels, Belgium
来源：
ACTA GASTRO-ENTEROLOGICA BELGICA | 2010年 / 73卷 / 03期
关键词：
azathioprine; 6-thioguanine nucleotides (6-TGN); 6-methylmercaptopurine (6-MMP); thiopurine metabolism; thiopurine side effects; S-METHYLTRANSFERASE; CROHNS-DISEASE; AZATHIOPRINE THERAPY; COST-EFFECTIVENESS; TPMT ACTIVITY; PHARMACOGENETICS; 6-MERCAPTOPURINE; MERCAPTOPURINE; ALLOPURINOL; MYELOSUPPRESSION;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side-effects and inefficacy are a major concern as they lead to withdrawal of the drug. Tools investigating TP metabolism are useful to avoid inadequate cessation of TP therapy. TP metabolism is complex and many enzymes are involved. Among them, Thiopurine methyltransferase (TPMT) is the only one routinely measured by pheno- or genotyping. In this review, the rationale for TPMT and thiopurine metabolites, 6-thioguanine nucleotides and 6-methylmercaptopurine, determination in clinical practice is discussed, specifically in case of thiopurine failure and recommendations are given about their interpretation and potential dose optimization of TP drugs. (Acta gastroenterolog. belg., 2010, 73, 331-335)
引用
收藏
页码：331 / 335
页数：5
相关论文
共 50 条
  • [41] Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients
    Gonzalez-Lama, Y.
    Bermejo, F.
    Lopez-Sanroman, A.
    Garcia-Sanchez, V.
    Esteve, M.
    Cabriada, J. L.
    McNicholl, A. G.
    Pajares, R.
    Casellas, F.
    Merino, O.
    Carpio, D.
    Vera, M. I.
    Munoz, C.
    Calvo, M.
    Benito, L. M.
    Bujanda, L.
    Garcia-Fernandez, F. J.
    Ricart, E.
    Ginard, D.
    Velasco, M.
    Carneros, J. A.
    Mancenido, N.
    Calvo, M.
    Algaba, A.
    Froilan, C.
    Cara, C.
    Mate, J.
    Abreu, L.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (05) : 544 - 554
  • [42] Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease
    Sanchez Rodriguez, Eugenia
    Rios Leon, Raquel
    Mesonero Gismero, Francisco
    Albillos, Agustin
    Lopez-Sanroman, Antonio
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (10): : 629 - 635
  • [43] Thiopurine methyltransferase activity in the inflammatory bowel disease.: A study on 7046 Spanish patients
    Gisbert, JP
    Gomollón, F
    Cara, C
    Luna, M
    González-Lama, Y
    Pajares, JM
    Maté, J
    Guijarro, LG
    MEDICINA CLINICA, 2005, 125 (08): : 281 - 285
  • [44] Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients
    Derijks, L. J. J.
    van Helden, R. B.
    Hommes, D. W.
    Stokkers, P. C.
    GUT, 2008, 57 (06) : 872 - 872
  • [45] The role of thiopurine methyltransferase (TPMT) activity assay before commencing thiopurine drugs in inflammatory bowel disease (IBD)
    Wong, JLH
    Lowes, J
    Biggs, L
    Galloway, TS
    McGovern, D
    Dymond, H
    Hussaini, H
    Dalton, H
    GASTROENTEROLOGY, 2002, 122 (04) : A222 - A222
  • [46] Relevance of thiopurine methyltransferase mutation screening in patients with inflammatory bowel disease in Cape Town
    Mokhele, Nnete
    Setshedi, Mashiko
    Sungay, Yaseen
    Epstein, David
    Watermeyer, Gillian
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2018, 108 (08): : 690 - 690
  • [47] Thiopurine-methyltransferase variants in inflammatory bowel disease: Prevalence and toxicity in Brazilian patients
    Carvalho, Ana Teresa P.
    Esberard, Barbara C.
    Froes, Renata S. B.
    Rapozo, Davy C. M.
    Grinman, Ana B.
    Simao, Tatiana A.
    Santos, Juliana C. V. C.
    Carneiro, Antonio Jose V.
    Ribeiro-Pinto, Luis Felipe
    de Souza, Heitor S. P.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (12) : 3327 - 3334
  • [48] HIGH PREVALENCE OF POLYMORPHISM AND LOW ACTIVITY OF THIOPURINE METHYLTRANSFERASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Larussa, T.
    Lentini, M.
    Nazionale, I.
    Suraci, E.
    Gallo, L.
    Mancuso, S.
    Larosa, E.
    Abenavoli, L.
    Imeneo, M.
    Luzza, F.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S183 - S184
  • [49] High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease
    Larussa, Tiziana
    Suraci, Evelina
    Lentini, Margherita
    Nazionale, Immacolata
    Gallo, Luigia
    Abenavoli, Ludovico
    Imeneo, Maria
    Costanzo, Francesco Saverio
    Cuda, Giovanni
    Luzza, Francesco
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (03) : 273 - 277
  • [50] Thiopurine-methyltransferase variants in inflammatory bowel disease:Prevalence and toxicity in Brazilian patients
    Ana Teresa P Carvalho
    Barbara C Esberard
    Renata S B Fróes
    Davy C M Rapozo
    Ana B Grinman
    Tatiana A Simo
    Juliana C V C Santos
    Antonio José V Carneiro
    Luis Felipe Ribeiro-Pinto
    Heitor S P de Souza
    World Journal of Gastroenterology, 2014, (12) : 3327 - 3334
12345